Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Gulick AM et al. | Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. | 2000 | Biochemistry | pmid:10769114 |
Tian B et al. | Predicting enzyme-substrate specificity with QM/MM methods: a case study of the stereospecificity of (D)-glucarate dehydratase. | 2013 | Biochemistry | pmid:23901785 |
Tiwari P et al. | Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. | 2016 | Biochimie | pmid:26655363 |
Ferioli A et al. | Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers. | 1989 Jul-Sep | Biol Trace Elem Res | pmid:2484601 |
Singh J and Gupta KP | Calcium glucarate prevents tumor formation in mouse skin. | 2003 | Biomed. Environ. Sci. | pmid:12747003 |
Fujii Y et al. | Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). | 2000 | Biomed. Pharmacother. | pmid:10759292 |
Conner TA et al. | Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose. | 2012 | Biometals | pmid:22706571 |
Pai AB et al. | Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. | 2011 | Biometals | pmid:21229380 |
Shiue E et al. | Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. | 2015 | Biotechnol. Bioeng. | pmid:25258165 |
Adzharov D et al. | [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats]. | 1989 | Biull Eksp Biol Med | pmid:2914170 |
Ageeva TA and ShkurupiÄ VA | [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate]. | 1994 | Biull Eksp Biol Med | pmid:7522618 |
Bhandal N and Russell R | Intravenous versus oral iron therapy for postpartum anaemia. | 2006 | BJOG | pmid:17004982 |
Perelló MF et al. | Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. | 2014 | BJOG | pmid:24423186 |
WHITE LP et al. | The immediate hematologic effects of intravenous saccharated iron oxide. | 1952 | Blood | pmid:14953947 |
HOLLY RG | Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology. | 1951 | Blood | pmid:14869375 |
Breymann C | Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. | 2002 Nov-Dec | Blood Cells Mol. Dis. | pmid:12547241 |
Price E et al. | A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. | 2014 | Blood Cells Mol. Dis. | pmid:25065855 |
Eiselt J et al. | The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. | 2006 | Blood Purif. | pmid:17077626 |
Breborowicz A et al. | Intravenous iron sucrose changes the intraperitoneal homeostasis. | 2009 | Blood Purif. | pmid:19325240 |
Li H and Wang SX | Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. | 2008 | Blood Purif. | pmid:18212498 |
Gemici C et al. | Is there any role of intravenous iron for the treatment of anemia in cancer? | 2016 | BMC Cancer | pmid:27542823 |
Iversen C et al. | The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. | 2007 | BMC Evol. Biol. | pmid:17439656 |
Rodionov DA et al. | Genomic encyclopedia of sugar utilization pathways in the Shewanella genus. | 2010 | BMC Genomics | pmid:20836887 |
Dong T and Schellhorn HE | Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. | 2009 | BMC Genomics | pmid:19650909 |
Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
Kell DB | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. | 2009 | BMC Med Genomics | pmid:19133145 |
Di Nocera PP et al. | Genome organization of epidemic Acinetobacter baumannii strains. | 2011 | BMC Microbiol. | pmid:21985032 |
Barraclough KA et al. | Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). | 2009 | BMC Nephrol | pmid:19635169 |
Manley HJ and Grabe DW | Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study. | 2004 | BMC Nephrol | pmid:14718064 |
Pollak VE et al. | The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. | 2009 | BMC Nephrol | pmid:19245700 |
Shimizu Y et al. | Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. | 2009 | Bone | pmid:19555782 |
Spencer-Peet J et al. | Urinary d-glucaric acid excretion and serum gamma-glutamyl transpeptidase activity in alcoholism. | 1975 | Br J Addict Alcohol Other Drugs | pmid:2272 |
Muñoz M et al. | Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. | 2012 | Br J Anaesth | pmid:22337966 |
Basora M et al. | Optimizing preoperative haemoglobin with intravenous iron. | 2013 | Br J Anaesth | pmid:23404979 |
Bisbe E et al. | A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. | 2011 | Br J Anaesth | pmid:21841061 |
Tokola O et al. | Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. | 1975 | Br J Clin Pharmacol | pmid:786355 |
Labadarios D et al. | The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. | 1978 | Br J Clin Pharmacol | pmid:23138 |
Park BK | Assessment of the drug metabolism capacity of the liver. | 1982 | Br J Clin Pharmacol | pmid:6128018 |
Boase S and Miners JO | In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. | 2002 | Br J Clin Pharmacol | pmid:12445028 |
Fuchs W et al. | Lansoprazole does not affect the bioavailability of oral contraceptives. | 1994 | Br J Clin Pharmacol | pmid:7833230 |
Heinemeyer G et al. | D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. | 1986 | Br J Clin Pharmacol | pmid:2868749 |
Németh I and Szeleczki T | Enhanced drug metabolism and renal dysfunction. | 1981 | Br J Clin Pharmacol | pmid:7213515 |
Ylikallio A and Sotaniemi EA | Drug metabolism and liver function after methyldopa withdrawal. | 1980 | Br J Clin Pharmacol | pmid:7426273 |
Perucca E et al. | A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. | 1980 | Br J Clin Pharmacol | pmid:7437261 |
Makki KA et al. | Overnight urine specimens for the determination of D-glucaric acid excretion in man. | 1979 | Br J Clin Pharmacol | pmid:486295 |
Perucca E et al. | The comparative enzyme-inducing properties of antiepileptic drugs [proceedings]. | 1979 | Br J Clin Pharmacol | pmid:444364 |
Oxley J et al. | Lack of hepatic enzyme inducing effect of sodium valproate. | 1979 | Br J Clin Pharmacol | pmid:385027 |
Barot MH et al. | Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy. | 1978 | Br J Clin Pharmacol | pmid:687505 |
Stevens PM et al. | Urinary D-glucaric acid and oral contraceptives. | 1978 | Br J Clin Pharmacol | pmid:656297 |
Henry DA et al. | The [14C]-aminopyrine breath test. A comparison of different forms of analysis. | 1979 | Br J Clin Pharmacol | pmid:533576 |